TUBGCP2

Across TCGA pan-cancer cohorts, TUBGCP2 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TUBGCP2 data layer compared with 26 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher TUBGCP2 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated TUBGCP2 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LUAD show a favorable association.

CCRCC, PDAC, and HNSC are the cancer types where TUBGCP2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	III,IV	0.887	0.455	<.001	57	view →
PDAC	DFS	Median	IV	0.214	0.785	.006	18	view →
HNSC	DFS	Tertile	III,IV	0.682	0.924	.013	14	view →
LUAD	DFS	Quartile	II,III,IV	1.000	0.797	.037	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TUBGCP2–CCRCC (OS)

Open the CCRCC breakdown →